FFTY:ARCA-Innovator IBD 50 Fund

ETF | Others | NYSE Arca

Last Closing

USD 35.83

Change

+0.15 (+0.42)%

Market Cap

USD 0.07B

Volume

0.11M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

The investment seeks long-term capital appreciation. Under normal circumstances, the fund will invest at least 80% of its net assets (plus borrowings for investment purposes) in companies included in the IBD? 50 Index. The fund will generally hold all of the companies included in the IBD? 50 Index other than during periods when the fund is rebalanced due to changes in the constitution of the IBD? 50 Index. The fund, however, will not invest in the IBD? 50 Index companies in the same proportion as reflected in the index.

Inception Date: 08/04/2015

Primary Benchmark: IBD 50 Index USD

Primary Index: S&P 500 TR USD

Gross Expense Ratio: 1.13%

Management Expense Ratio: 0.80 %

Unadjusted Closing Price

Adjusted Closing Price

Assets

N/A

Top Holdings

N/A

Symbol Company Name Allocation
LFUS Littelfuse Inc 3.36 %
Top Sectors

N/A

Top Regions

N/A

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2019-07-15 )

Largest Industry Peers for Others

Symbol Name Mer Price(Change) Market Cap
SOJE SOJE 0.00 %

-0.08 (-0.39%)

USD 65.72B
ITDC Ishares Lifepath Target Date 2.. 0.00 %

+0.16 (+0.56%)

USD 36.86B
JEPI JPMorgan Equity Premium Income.. 0.00 %

+0.35 (+0.61%)

USD 32.78B
LCR Leuthold Core ETF 0.00 %

+0.22 (+0.66%)

USD 32.52B
DTB DTB 0.00 %

-0.30 (-1.44%)

USD 26.58B
DFAC Dimensional U.S. Core Equity 2.. 0.00 %

+0.38 (+1.21%)

USD 26.11B
JPST JPMorgan Ultra-Short Income ET.. 0.00 %

+0.02 (+0.04%)

USD 22.47B
SGOV iShares® 0-3 Month Treasury B.. 0.00 %

+0.05 (+0.05%)

USD 18.58B
TSPA T. Rowe Price US Equity Resear.. 0.00 %

+0.24 (+0.72%)

USD 16.23B
DFUV Dimensional US Marketwide Valu.. 0.00 %

+0.63 (+1.57%)

USD 10.15B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange (NYSE Arca)
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 29.72% 94% A 85% B
Dividend Return N/A N/A N/A N/A F
Total Return 29.72% 93% A 83% B
Trailing 12 Months  
Capital Gain -2.37% 36% F 44% F
Dividend Return N/A N/A N/A N/A F
Total Return -2.37% 30% F 38% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A F
Dividend Return N/A N/A N/A N/A F
Total Return N/A N/A N/A N/A F
Average Annual (5 Year Horizon)  
Capital Gain 11.25% 94% A 68% D+
Dividend Return 11.30% 83% B 64% D
Total Return 0.05% 11% F 2% F
Risk Return Profile  
Volatility (Standard Deviation) 18.58% 11% F 66% D+
Risk Adjusted Return 60.82% 39% F 79% B-
Market Capitalization 0.07B 69% C- 41% F

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.